Transcription-replication conflicts underlie sensitivity to PARP inhibitors

Michalis Petropoulos1, Angeliki Karamichali1, Giacomo G Rossetti2

  • 1Department of Molecular and Cellular Biology, University of Geneva, Geneva, Switzerland.

Nature
|March 21, 2024
PubMed

Insights

Poly(ADP-ribose) polymerase (PARP) inhibitors combat homologous recombination (HR)-deficient cancers by protecting the replisome. Their efficacy stems from repairing DNA damage during transcription-replication conflicts, not solely from trapping PARPs.

Area of Science:

  • Molecular Biology
  • Cancer Therapeutics
  • Genetics

Background:

  • Poly(ADP-ribose) polymerase (PARP) inhibitors are crucial for treating homologous recombination (HR)-deficient cancers.
  • PARP inhibitors are believed to trap PARPs on DNA, blocking replication and causing DNA double-strand breaks that necessitate HR for repair.

Purpose of the Study:

  • To investigate the precise mechanism underlying the synthetic lethality of PARP inhibitors in HR-deficient cancers.
  • To elucidate the role of PARP1, TIMELESS, and TIPIN in protecting the replication machinery.

Main Methods:

  • Investigated the interaction of PARP1 with TIMELESS and TIPIN in early S phase.
  • Analyzed the impact of inhibiting transcription elongation on PARP inhibitor sensitivity in HR-deficient cells.
  • Utilized small-interfering RNA to deplete PARP1 and assess its effect on HR-deficient cells.

Main Results:

  • PARP1, TIMELESS, and TIPIN collaborate to shield the replisome from transcription-replication conflicts in early S phase.
  • The synthetic lethality observed with PARP inhibitors in HR-deficient cells is attributed to unrepaired DNA damage from transcription-replication conflicts.
  • Inhibiting transcription elongation rendered HR-deficient cells resistant to PARP inhibitors, and PARP1 depletion showed synthetic lethality with HR deficiency.

Conclusions:

  • The therapeutic effect of PARP inhibitors in HR-deficient cancers may be achieved by targeting PARP1's enzymatic activity alone.
  • Understanding the role of PARP1 in DNA repair during replication stress is critical for optimizing cancer therapy.

Related Concept Videos

The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
35.9K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
10.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Genome Copying Errors02:46

Genome Copying Errors

DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their  survival. Therefore, the copying errors are checked and repaired at three levels.
4.2K